Trial Profile

Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma

Status: Not yet recruiting

Phase of Trial: Phase II

Latest Information Update: 09 Apr 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Non Hodgkin's lymphoma vaccine XEME Biopharma (Primary)
Indications Follicular lymphoma
Focus Therapeutic Use
Sponsors XEME Biopharma

Most Recent Events

07 Apr 2021 Planned End Date changed from 1 Jan 2023 to 1 Jun 2026.
07 Apr 2021 Planned primary completion date changed from 1 Jan 2022 to 1 Jun 2024.
07 Apr 2021 Planned initiation date changed from 1 Jan 2020 to 1 Jul 2021.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com